"Xerostomia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Decreased salivary flow.
Descriptor ID |
D014987
|
MeSH Number(s) |
C07.465.815.929
|
Concept/Terms |
Xerostomia- Xerostomia
- Xerostomias
- Hyposalivation
- Hyposalivations
- Asialia
- Asialias
- Mouth Dryness
- Dryness, Mouth
|
Below are MeSH descriptors whose meaning is more general than "Xerostomia".
Below are MeSH descriptors whose meaning is more specific than "Xerostomia".
This graph shows the total number of publications written about "Xerostomia" by people in this website by year, and whether "Xerostomia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 2 | 1 | 3 |
1997 | 1 | 0 | 1 |
1998 | 1 | 0 | 1 |
1999 | 0 | 1 | 1 |
2000 | 1 | 1 | 2 |
2002 | 1 | 0 | 1 |
2003 | 4 | 0 | 4 |
2004 | 1 | 3 | 4 |
2005 | 2 | 0 | 2 |
2006 | 6 | 0 | 6 |
2007 | 4 | 1 | 5 |
2008 | 1 | 0 | 1 |
2009 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
2011 | 2 | 1 | 3 |
2012 | 2 | 0 | 2 |
2013 | 0 | 2 | 2 |
2014 | 3 | 1 | 4 |
2015 | 1 | 1 | 2 |
2016 | 0 | 2 | 2 |
2017 | 1 | 1 | 2 |
2018 | 0 | 1 | 1 |
2019 | 2 | 1 | 3 |
2021 | 3 | 0 | 3 |
2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Xerostomia" by people in Profiles.
-
Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Sci Rep. 2022 04 22; 12(1):6662.
-
Cross-Cultural Brain Activity Differences Between True and Sham Acupuncture for Xerostomia During Head and Neck Cancer Radiotherapy. Integr Cancer Ther. 2022 Jan-Dec; 21:15347354221101630.
-
Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. Cancer. 2021 12 01; 127(23):4470-4480.
-
Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline. J Clin Oncol. 2021 09 01; 39(25):2825-2843.
-
Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. Radiother Oncol. 2021 07; 160:32-39.
-
Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2019 12 02; 2(12):e1916910.
-
Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy. Radiother Oncol. 2020 01; 142:133-139.
-
Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation. Radiother Oncol. 2020 01; 142:100-106.
-
Modeling symptom drivers of oral intake in long-term head and neck cancer survivors. Support Care Cancer. 2019 Apr; 27(4):1405-1415.
-
Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol. 2018 01; 126(1):75-80.